Drug Database
Back to search

Netherlands· NL-ab717e8032da

Clomifeencitraat CF 50 mg, tabletten

A clomifene product containing clomifeendiwaterstofcitraat, registered in Netherlands by Centrafarm B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC G03GB02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedClomifeencitraat CF 50 mg, tablettenATCG03GB02REGISTER NO.NL-ab717e8032daPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clomifeendiwaterstofcitraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clomifene is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GB02 (clomifene), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search clomifene products by name

Clomifene · ATC G03GB02

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of clomifene costs, country by country.

Normalised to the WHO defined daily dose (9 mg), the median price runs from $0.10 in Italy to $0.76 in United States — a ×7.3 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Clomifene · price per daily dose (9 mg)

USD · FX 28 Sept 2026

  • US United States$0.76 (acquisition cost)
  • FR France$0.14
  • IT Italy$0.10
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CLOMIFEENDIWATERSTOFCITRAAT
Manufacturer
Centrafarm B.V.
Country
Netherlands (NL)
ATC code
G03GB02
ATC class
Clomifene
Defined daily dose
9 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    53363

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for clomifene.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clomifene against other medicinesHow interaction checks work

Clomifene · interactions on record

2 records

  • 2 severe

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clomifene in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clomifene products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0784dbeb-e64c-4374-ad75-09110b4a8d9b
GET /v1/drugs/0784dbeb-e64c-4374-ad75-09110b4a8d9b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h53363_smpc.pdf",
  "strength": null,
  "atc_label": "Clomifene",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg53363",
  "excipients": [
    "AARDAPPELZETMEEL",
    "CHINOLINEGEEL (E 104)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POVIDON K 90 (E 1201)",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)"
  ],
  "substances": [
    "CLOMIFEENDIWATERSTOFCITRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h53363.pdf",
  "authorised_at": "1992/10/05",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "53363",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about clomifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console